The Characteristics of Treated Pulmonary Arterial Hypertension Patients in Ontario
Background. There are no Canadian prevalence studies on pulmonary arterial hypertension (PAH) to date. We described the characteristics of treated PAH patients and the healthcare utilization and costs associated with PAH in a population of public drug plan beneficiaries in Ontario, Canada. Methods....
Saved in:
Main Authors: | Haris M. Vaid, Ximena Camacho, John T. Granton, Muhammad M. Mamdani, Zhan Yao, Samantha Singh, David N. Juurlink, Tara Gomes |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2016-01-01
|
Series: | Canadian Respiratory Journal |
Online Access: | http://dx.doi.org/10.1155/2016/6279250 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An Open-Label, Multicentre Pilot Study of Bosentan in Pulmonary Arterial Hypertension Related to Congenital Heart Disease
by: Reda Ibrahim, et al.
Published: (2006-01-01) -
Goiter in a Patient with Pulmonary Arterial Hypertension Treated with Epoprostenol
by: Shaadi Abughazaleh, et al.
Published: (2020-01-01) -
Canadian Cardiovascular Society and Canadian Thoracic Society Position Statement on Pulmonary Arterial Hypertension
by: David Langleben, et al.
Published: (2005-01-01) -
Dasatinib-Induced Pulmonary Arterial Hypertension Treated with Upfront Combination Therapy
by: Makoto Nishimori, et al.
Published: (2018-01-01) -
New therapies in pulmonary arterial hypertension: Recent insights
by: Giulia Guglielmi, et al.
Published: (2025-03-01)